← Eichor
Study identifier: NCT04755764 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Pregnancy

Condition: Systolic Hypertension · Pregnancy Related · Diastolic Hypertension  ·  Sponsor: Marshall University

PhaseN/A
Planned participants60
Who can joinFemale, 18 Years to 45 Years
Healthy volunteersYes

About this study

The purpose of the research is to characterize the effect of labetalol, atenolol, and nifedipine on maternal hemodynamics early in pregnancy. Patients will be given medication based on their hemodynamics and asked to return for a repeat measurement.

This description comes directly from the study's public registry record.

Talk to the study team

Morgan Ruley, MS  ·  (304) 691-1458  ·  kelley115@marshall.edu

Jesse Cottrell, MD  ·  (304) 691-1400  ·  cottrellje@marshall.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Maternal Hypertension Center at Cabell Huntington HospitalHuntington, West Virginia, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04755764